tiprankstipranks
Tonix Pharmaceuticals (TNXP)
NASDAQ:TNXP
US Market
TNXP
Tonix Pharma
RESEARCH TOOLSreports

Tonix Pharma (TNXP) Income Statement

Compare
5,060 Followers

Tonix Pharma Income Statement

Last quarter (Q4 2025), Tonix Pharma's total revenue was $5.39M, an increase of 108.75% from the same quarter last year. In Q4, Tonix Pharma's net income was $-46.91M. See Tonix Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Mar 24Dec 22Dec 21
Total Revenue
$ 13.11M$ 10.09M$ 7.77M$ 0.00$ 0.00
Gross Profit
$ 6.47M$ 2.33M$ 3.03M$ 0.00$ 0.00
Operating Expenses
$ 132.17M$ 139.03M$ 121.41M$ 112.09M$ 92.31M
Depreciation and Amortization
$ 1.93M$ 3.42M$ 4.29M$ 1.25M$ 50.00K
EBITDA
$ -123.78M$ -74.32M$ -114.09M$ -110.84M$ -92.26M
Operating Income
$ -125.70M$ -136.70M$ -118.38M$ -112.09M$ -92.31M
Other Income/Expenses
$ 1.68M$ 6.67M$ 1.72M$ 1.87M$ 25.00K
Pretax Income
$ -124.02M$ -130.04M$ -116.66M$ -110.22M$ -92.29M
Net Income
$ -124.02M$ -130.04M$ -116.66M$ -110.22M$ -92.29M
Per Share Metrics
Basic EPS
$ -14.57$ -176.60$ -6.37K$ -811.68$ -163.97K
Diluted EPS
$ -14.57$ -176.60$ -6.37K$ -811.68$ -163.97K
Weighted Average Shares Outstanding
 8.51M 2.26M 1.83M 3.07M-
Weighted Average Shares Outstanding (Diluted)
 8.51M 2.26M 1.83M 3.07M-
Currency in USD

Tonix Pharma Earnings and Revenue History